Department of Nanomedicine

Nanomedicine
The Department of Nanomedicine focuses on interdisciplinary research by combining nanoengineering, mathematical modeling and biomedical sciences to develop nanotechnology-enabled therapeutic and diagnostic platforms for combating diseases including cancer, cardiovascular diseases and infectious diseases. Our research spans a wide range of areas including personalized nanochannel drug delivery systems, injectable nanovectors that achieve desired therapeutic concentrations in target tissue, discovery of new protein biomarkers through proteomics, developing biodegradable synthetic polymers with the biological functions of natural biomaterial scaffolds, and microfluidics for disease diagnostics.
INJECTABLE NANOPARTICLE GENERATOR FOR METASTATIC BREAST CANCER TREATMENT

Mauro Ferrari, PhD, president and CEO of the Houston Methodist Research Institute, and his team have developed the first drug delivery system to successfully eliminate lung metastases in mice models with triple negative breast cancer. Learn more.


Department of Nanomedicine Chair

Alessandro Grattoni, PhD
Assistant Professor of Nanomedicine, Institute for Academic Medicine
Chair, Department of Nanomedicine
Houston Methodist

Methodist in Space

Houston Methodist received about $1.25 million from the Center for the Advancement of Science in Space (CASIS) to develop an implantable device that delivers therapeutic drugs at a rate guided by remote control. Learn more.

Contact

Department of Nanomedicine
Houston Methodist Research Institute
6670 Bertner Ave.
Houston, TX 77030
713.441.1261